🇺🇸 FDA
Patent

US 7858635

Spiro compounds as modulators of muscarinic receptors

granted A61KA61K31/438A61K31/4545

Quick answer

US patent 7858635 (Spiro compounds as modulators of muscarinic receptors) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/438, A61K31/4545, A61K31/46, A61K31/497